Article
Combinatorial targeting of XPO1 and FLT3 exerts synergistic anti-leukemia effects through induction of differentiation and apoptosis in FLT3-mutated acute myeloid leukemias: from concept to clinical trial.
Haematologica - 1 Oct 2018
Zhang Weiguo, Ly Charlie, Ishizawa Jo, Mu Hong, Ruvolo Vivian, Shacham Sharon, Daver Naval, Andreeff Michael
Abstract excerpt
Targeted therapies against FLT3-mutated acute myeloid leukemias have shown limited clinical efficacy primarily because of the acquisition of secondary mutations in FLT3 and persistent activation of downstream pro-survival pathways such as MEK/ERK, PI3K/AKT, and STAT5. Activation of these additional kinases may also result in phosphorylation of tumor suppressor proteins promoting their nuclear export. Thus,...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.